Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
The SuperPATH approach is a minimally invasive approach for total hip arthroplasty. This project randomized patients to the SuperPath versus posterior approach. Outcomes examined included functional, VAS pain, narcotic utilization, perioperative outcomes, and radiographic component positions. Participants were followed for 2 years. The aim was to examine if the SuperPATH approach provided significant advantages over the posterior approach on functional testing or return to work for patients.
Eligible Conditions
- Hip Arthritis
- Surgical Approach
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Functional Outcomes TSC
Functional Outcomes TUG
Secondary outcome measures
Pain Score
Subjective Measure
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SuperpathExperimental Treatment1 Intervention
This is a minimally invasive surgical approach.
Group II: Posterior ApproachActive Control1 Intervention
This is the traditional THA surgical approach used.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Superpath Approach
2017
Completed Phase 4
~50
Find a Location
Who is running the clinical trial?
Queen's UniversityLead Sponsor
371 Previous Clinical Trials
123,893 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger